Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027638
Status:
COMPLETED
Last Update Posted:
2013-06-18
First Post:
2001-12-07
Brief Title:
Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Phase II Trial Of Thalidomide In Patients With Low Grade Neuroendocrine Tumors Carcinoid and Islet Cell Cancers
Status:
COMPLETED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Thalidomide may stop the growth of neuroendocrine tumors by stopping blood flow to the tumor
PURPOSE Phase II trial to study the effectiveness of thalidomide in treating patients who have metastatic neuroendocrine tumors
PURPOSE Phase II trial to study the effectiveness of thalidomide in treating patients who have metastatic neuroendocrine tumors
Detailed Description:
OBJECTIVES
Determine the safety and efficacy of thalidomide in patients with metastatic low-grade neuroendocrine tumors
OUTLINE Patients receive oral thalidomide once daily on weeks 1-8 Courses repeat every 8 weeks in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL A total of 14-25 patients will be accrued for this study
Determine the safety and efficacy of thalidomide in patients with metastatic low-grade neuroendocrine tumors
OUTLINE Patients receive oral thalidomide once daily on weeks 1-8 Courses repeat every 8 weeks in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL A total of 14-25 patients will be accrued for this study
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-G01-2029 | Registry Identifier | PDQ Physician Data Query | None |
| CDR0000069051 | REGISTRY | None | None |